Sabra Healthcare REIT, Inc. $SBRA Shares Sold by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. reduced its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 0.9% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 3,408,114 shares of the real estate investment trust’s stock after selling 31,267 shares during the period. Sumitomo Mitsui Trust Group Inc.’s holdings in Sabra Healthcare REIT were worth $67,208,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Dimensional Fund Advisors LP lifted its position in Sabra Healthcare REIT by 7.8% during the first quarter. Dimensional Fund Advisors LP now owns 3,725,337 shares of the real estate investment trust’s stock worth $71,640,000 after purchasing an additional 269,793 shares during the period. Readystate Asset Management LP acquired a new stake in Sabra Healthcare REIT during the second quarter worth about $1,400,000. Entropy Technologies LP grew its stake in Sabra Healthcare REIT by 299.6% during the first quarter. Entropy Technologies LP now owns 124,068 shares of the real estate investment trust’s stock worth $2,386,000 after buying an additional 93,021 shares in the last quarter. Quantinno Capital Management LP increased its holdings in Sabra Healthcare REIT by 424.3% in the 1st quarter. Quantinno Capital Management LP now owns 155,086 shares of the real estate investment trust’s stock valued at $2,982,000 after buying an additional 125,507 shares during the period. Finally, NewEdge Advisors LLC increased its holdings in Sabra Healthcare REIT by 261.2% in the 2nd quarter. NewEdge Advisors LLC now owns 71,128 shares of the real estate investment trust’s stock valued at $1,388,000 after buying an additional 51,435 shares during the period. Institutional investors own 99.40% of the company’s stock.

Key Headlines Impacting Sabra Healthcare REIT

Here are the key news stories impacting Sabra Healthcare REIT this week:

• Positive Sentiment: Sabra raised its 2026 EPS guidance to $1.54–$1.55, above the prior analyst consensus of $1.52. Management also expects 7%–8% year-over-year earnings growth in 2026. Read More.
• Positive Sentiment: Third-quarter revenue rose 31.4% year over year to about $249.6 million, topping the roughly $236.6 million analyst estimate. A report also said quarterly FFO of $0.41 per share beat the $0.40 consensus. Read More.
• Positive Sentiment: Sabra is targeting 50% exposure to its senior housing operating portfolio (SHOP) by the end of 2027. Its CEO pointed to asset optimization and lease negotiations as additional sources of potential upside. Read More. · Read More.
• Positive Sentiment: The REIT declared a quarterly dividend of $0.30 per share, equivalent to $1.20 annually and a reported yield of 6%. Read More.
• Negative Sentiment: Reported third-quarter EPS was $0.11, below the $0.16 consensus and down from $0.38 a year earlier. This earnings shortfall tempers the stronger revenue and outlook news. Read More.

Insider Activity at Sabra Healthcare REIT

In other Sabra Healthcare REIT news, CEO Richard Matros sold 200,000 shares of the company’s stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $20.83, for a total value of $4,166,000.00. Following the sale, the chief executive officer owned 1,657,686 shares in the company, valued at approximately $34,529,599.38. The trade was a 10.77% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 1.09% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on SBRA. Citizens Jmp boosted their target price on shares of Sabra Healthcare REIT from $23.00 to $25.00 and gave the company a “market outperform” rating in a research report on Wednesday, July 22nd. Mizuho set a $21.00 price objective on shares of Sabra Healthcare REIT in a research note on Monday, August 31st. UBS Group cut their target price on Sabra Healthcare REIT from $21.00 to $20.00 and set a “neutral” rating for the company in a research note on Tuesday, October 13th. Huntington initiated coverage on Sabra Healthcare REIT in a report on Thursday, September 10th. They issued an “outperform” rating and a $23.00 target price on the stock. Finally, Wells Fargo & Company decreased their price target on Sabra Healthcare REIT from $23.00 to $21.00 and set an “overweight” rating on the stock in a research note on Monday, October 19th. Seven investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat, Sabra Healthcare REIT has an average rating of “Moderate Buy” and an average target price of $21.50.

Sabra Healthcare REIT Trading Up 3.2%

Shares of NASDAQ SBRA opened at $20.35 on Wednesday. The firm has a 50 day moving average price of $19.85 and a two-hundred day moving average price of $19.97. The stock has a market cap of $5.20 billion, a P/E ratio of 72.68, a price-to-earnings-growth ratio of 1.79 and a beta of 0.68. Sabra Healthcare REIT, Inc. has a 52-week low of $17.53 and a 52-week high of $22.77. The company has a debt-to-equity ratio of 0.95, a quick ratio of 3.07 and a current ratio of 3.07.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Monday, November 2nd. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.05). Sabra Healthcare REIT had a return on equity of 2.56% and a net margin of 7.78%. The business had revenue of $249.57 million for the quarter, compared to analyst estimates of $236.64 million. During the same quarter last year, the firm posted $0.38 EPS. Sabra Healthcare REIT’s revenue for the quarter was up 31.4% on a year-over-year basis. As a group, equities analysts forecast that Sabra Healthcare REIT, Inc. will post 1.52 EPS for the current year.

Sabra Healthcare REIT Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, November 30th. Shareholders of record on Friday, November 13th will be issued a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, November 13th. This represents a $1.20 annualized dividend and a yield of 5.9%. Sabra Healthcare REIT’s payout ratio is presently 461.54%.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc is a self-managed real estate investment trust that owns and invests in healthcare-related real estate. The company focuses primarily on properties used for skilled nursing and transitional care, senior housing, behavioral health, specialty hospitals and other healthcare services.

Sabra leases properties to healthcare operators and also provides capital through loans, joint ventures and other real estate investments. Its portfolio is designed to support a range of care settings, including facilities serving seniors, patients requiring rehabilitation and individuals receiving behavioral healthcare.

Founded in 2010 and headquartered in Irvine, California, Sabra has expanded through acquisitions, development investments and strategic transactions, including its 2017 combination with Care Capital Properties.